The benefits of a standardized approach to opioid prescribing

David Patchett, Michael Grover, Molly Kresin, Michael Bryan, Jon Nordrum, Matthew Buras, Susan Pierce, Kristina McDaniel

Research output: Contribution to journalArticle

Abstract

Purpose The "opioid epidemic" in the United States has received increasing attention over the past few years. Most drug overdose deaths involve an opioid, and prescription opioid deaths have quadrupled since 1999. We sought to improve patient safety and adhere to clinical guidelines by standardizing opioid prescribing in our practice. Methods We implemented a standardized approach to opioid prescribing based on Arizona Department of Health Services guidelines. All of our providers received instruction on Arizona's Controlled Substance Prescription Monitoring Program (AZCSPMP) database and were encouraged to use it online. Our goal was for patients to have quarterly office visits, complete random urine drug screens, and sign a controlled substance agreement (CSA). The CSA acknowledged their understanding of the risks and benefits of opioid therapy as well as our updated prescribing policies. Results Three-hundred fifty-eight of our practice's patients were receiving chronic opioid therapy. All providers enrolled in AZCSPMP and used it for patient care. We increased rates of signed CSAs from 4.5% to 43.6%, and urine drug screening from 0.8% to 20.1%. For 325 patients remaining in the practice after our interventions, a postintervention chart review demonstrated a statistically significant discontinuation of opioid therapy (71/325, 21.8%; 95% confidence interval, 17.4%-26.7%). Conclusion Implementation of a standardized opioid prescribing process resulted in discontinuation of therapy for some patients. Rates increased for signed CSAs and completed random urine drug screening. Future process interventions may improve patient and provider adherence. All primary care physicians should examine their prescribing processes to enhance the safety of opioid therapy.

Original languageEnglish (US)
Pages (from-to)E1-E7
JournalJournal of Family Practice
Volume68
Issue number6
StatePublished - Jan 1 2019

Fingerprint

Opioid Analgesics
Controlled Substances
Prescriptions
Preclinical Drug Evaluations
Urine
Guidelines
Drug Overdose
Therapeutics
Office Visits
Primary Care Physicians
Patient Safety
Patient Compliance
Health Services
Patient Care
Databases
Confidence Intervals
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Family Practice

Cite this

Patchett, D., Grover, M., Kresin, M., Bryan, M., Nordrum, J., Buras, M., ... McDaniel, K. (2019). The benefits of a standardized approach to opioid prescribing. Journal of Family Practice, 68(6), E1-E7.

The benefits of a standardized approach to opioid prescribing. / Patchett, David; Grover, Michael; Kresin, Molly; Bryan, Michael; Nordrum, Jon; Buras, Matthew; Pierce, Susan; McDaniel, Kristina.

In: Journal of Family Practice, Vol. 68, No. 6, 01.01.2019, p. E1-E7.

Research output: Contribution to journalArticle

Patchett, D, Grover, M, Kresin, M, Bryan, M, Nordrum, J, Buras, M, Pierce, S & McDaniel, K 2019, 'The benefits of a standardized approach to opioid prescribing', Journal of Family Practice, vol. 68, no. 6, pp. E1-E7.
Patchett D, Grover M, Kresin M, Bryan M, Nordrum J, Buras M et al. The benefits of a standardized approach to opioid prescribing. Journal of Family Practice. 2019 Jan 1;68(6):E1-E7.
Patchett, David ; Grover, Michael ; Kresin, Molly ; Bryan, Michael ; Nordrum, Jon ; Buras, Matthew ; Pierce, Susan ; McDaniel, Kristina. / The benefits of a standardized approach to opioid prescribing. In: Journal of Family Practice. 2019 ; Vol. 68, No. 6. pp. E1-E7.
@article{09b0237bfed143a3b17c0c642720f14c,
title = "The benefits of a standardized approach to opioid prescribing",
abstract = "Purpose The {"}opioid epidemic{"} in the United States has received increasing attention over the past few years. Most drug overdose deaths involve an opioid, and prescription opioid deaths have quadrupled since 1999. We sought to improve patient safety and adhere to clinical guidelines by standardizing opioid prescribing in our practice. Methods We implemented a standardized approach to opioid prescribing based on Arizona Department of Health Services guidelines. All of our providers received instruction on Arizona's Controlled Substance Prescription Monitoring Program (AZCSPMP) database and were encouraged to use it online. Our goal was for patients to have quarterly office visits, complete random urine drug screens, and sign a controlled substance agreement (CSA). The CSA acknowledged their understanding of the risks and benefits of opioid therapy as well as our updated prescribing policies. Results Three-hundred fifty-eight of our practice's patients were receiving chronic opioid therapy. All providers enrolled in AZCSPMP and used it for patient care. We increased rates of signed CSAs from 4.5{\%} to 43.6{\%}, and urine drug screening from 0.8{\%} to 20.1{\%}. For 325 patients remaining in the practice after our interventions, a postintervention chart review demonstrated a statistically significant discontinuation of opioid therapy (71/325, 21.8{\%}; 95{\%} confidence interval, 17.4{\%}-26.7{\%}). Conclusion Implementation of a standardized opioid prescribing process resulted in discontinuation of therapy for some patients. Rates increased for signed CSAs and completed random urine drug screening. Future process interventions may improve patient and provider adherence. All primary care physicians should examine their prescribing processes to enhance the safety of opioid therapy.",
author = "David Patchett and Michael Grover and Molly Kresin and Michael Bryan and Jon Nordrum and Matthew Buras and Susan Pierce and Kristina McDaniel",
year = "2019",
month = "1",
day = "1",
language = "English (US)",
volume = "68",
pages = "E1--E7",
journal = "Journal of Family Practice",
issn = "0094-3509",
publisher = "Appleton-Century-Crofts",
number = "6",

}

TY - JOUR

T1 - The benefits of a standardized approach to opioid prescribing

AU - Patchett, David

AU - Grover, Michael

AU - Kresin, Molly

AU - Bryan, Michael

AU - Nordrum, Jon

AU - Buras, Matthew

AU - Pierce, Susan

AU - McDaniel, Kristina

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose The "opioid epidemic" in the United States has received increasing attention over the past few years. Most drug overdose deaths involve an opioid, and prescription opioid deaths have quadrupled since 1999. We sought to improve patient safety and adhere to clinical guidelines by standardizing opioid prescribing in our practice. Methods We implemented a standardized approach to opioid prescribing based on Arizona Department of Health Services guidelines. All of our providers received instruction on Arizona's Controlled Substance Prescription Monitoring Program (AZCSPMP) database and were encouraged to use it online. Our goal was for patients to have quarterly office visits, complete random urine drug screens, and sign a controlled substance agreement (CSA). The CSA acknowledged their understanding of the risks and benefits of opioid therapy as well as our updated prescribing policies. Results Three-hundred fifty-eight of our practice's patients were receiving chronic opioid therapy. All providers enrolled in AZCSPMP and used it for patient care. We increased rates of signed CSAs from 4.5% to 43.6%, and urine drug screening from 0.8% to 20.1%. For 325 patients remaining in the practice after our interventions, a postintervention chart review demonstrated a statistically significant discontinuation of opioid therapy (71/325, 21.8%; 95% confidence interval, 17.4%-26.7%). Conclusion Implementation of a standardized opioid prescribing process resulted in discontinuation of therapy for some patients. Rates increased for signed CSAs and completed random urine drug screening. Future process interventions may improve patient and provider adherence. All primary care physicians should examine their prescribing processes to enhance the safety of opioid therapy.

AB - Purpose The "opioid epidemic" in the United States has received increasing attention over the past few years. Most drug overdose deaths involve an opioid, and prescription opioid deaths have quadrupled since 1999. We sought to improve patient safety and adhere to clinical guidelines by standardizing opioid prescribing in our practice. Methods We implemented a standardized approach to opioid prescribing based on Arizona Department of Health Services guidelines. All of our providers received instruction on Arizona's Controlled Substance Prescription Monitoring Program (AZCSPMP) database and were encouraged to use it online. Our goal was for patients to have quarterly office visits, complete random urine drug screens, and sign a controlled substance agreement (CSA). The CSA acknowledged their understanding of the risks and benefits of opioid therapy as well as our updated prescribing policies. Results Three-hundred fifty-eight of our practice's patients were receiving chronic opioid therapy. All providers enrolled in AZCSPMP and used it for patient care. We increased rates of signed CSAs from 4.5% to 43.6%, and urine drug screening from 0.8% to 20.1%. For 325 patients remaining in the practice after our interventions, a postintervention chart review demonstrated a statistically significant discontinuation of opioid therapy (71/325, 21.8%; 95% confidence interval, 17.4%-26.7%). Conclusion Implementation of a standardized opioid prescribing process resulted in discontinuation of therapy for some patients. Rates increased for signed CSAs and completed random urine drug screening. Future process interventions may improve patient and provider adherence. All primary care physicians should examine their prescribing processes to enhance the safety of opioid therapy.

UR - http://www.scopus.com/inward/record.url?scp=85071170728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071170728&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - E1-E7

JO - Journal of Family Practice

JF - Journal of Family Practice

SN - 0094-3509

IS - 6

ER -